Page last updated: 2024-10-26

fenbendazole and Lymphoma, Non-Hodgkin

fenbendazole has been researched along with Lymphoma, Non-Hodgkin in 1 studies

Fenbendazole: Antinematodal benzimidazole used in veterinary medicine.
fenbendazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted at positons 2 and 5 by (methoxycarbonyl)amino and phenylsulfanediyl groups, respectively. A broad-spectrum anthelmintic, it is used, particularly in veterinary medicine, for the treatment of nematodal infections.

Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
La Perle, KM1
Piercy, RJ1
Long, JF1
Blomme, EA1

Other Studies

1 other study available for fenbendazole and Lymphoma, Non-Hodgkin

ArticleYear
Multisystemic, eosinophilic, epitheliotropic disease with intestinal lymphosarcoma in a horse.
    Veterinary pathology, 1998, Volume: 35, Issue:2

    Topics: Anabolic Agents; Animals; Anti-Infective Agents; Antinematodal Agents; Drug Therapy, Combination; Fa

1998